Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6784372aa482f6c62b3c468693641159 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 |
filingDate |
2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3969e853bfb974e0b812d0a08327c332 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39dea5d9661420ff28cbe671b02e12e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb4802be80556e13966dc873dd3b4015 |
publicationDate |
2020-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2776195-T3 |
titleOfInvention |
Factor VIII polypeptide formulations |
abstract |
A pharmaceutical composition comprising: (a) 50 IU / mL to 2500 IU / mL of an rFVIIIFc polypeptide; (b) 10 mg / mL to 25 mg / mL of sucrose; (c) 8.8 mg / mL to 14.6 mg / mL of sodium chloride (NaCl); (d) 0.75 mg / mL to 2.25 mg / mL of L-histidine; (e) 0.75 mg / mL to 1.5 mg / mL of calcium chloride dihydrate; and (f) 0.08 mg / mL to 0.25 mg / mL of polysorbate 20 or polysorbate 80. |
priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |